Cargando…

Successful immunomodulators for the treatment of COVID-19 have opened the pathway for comparative trials

Detalles Bibliográficos
Autores principales:	Gallagher, Jason C., Morgan, Rebecca L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575309/ https://www.ncbi.nlm.nih.gov/pubmed/36257548 http://dx.doi.org/10.1016/j.cmi.2022.10.016

Ejemplares similares

We have to get it right: Ensuring success
por: Mokdad, Ali H., et al.
Publicado: (2020)

Immunocompromised patients have been neglected in COVID-19 trials: a call for action
por: Trøseid, Marius, et al.
Publicado: (2022)

COVID 19: Have we nailed it?
por: Gogia, Atul
Publicado: (2021)

Commentary: Targeting herpetic keratitis by immunomodulation of IL-27 signaling
por: Joseph, Joveeta
Publicado: (2019)

Macrophage depletion: a potential immunomodulator treatment of endometriosis-associated pain?
por: D’Hooghe, Thomas M., et al.
Publicado: (2020)

Clinical trial registration during COVID-19 and beyond in the African context: what have we learned?
por: Mathebula, Lindi, et al.
Publicado: (2022)

Immunomodulation in COVID-19
por: Ingraham, Nicholas E, et al.
Publicado: (2020)

Immunomodulators: still having a role?
por: Venner, Jeffery M, et al.
Publicado: (2022)

Vietnam's success story against COVID-19
por: Nguyen Thi Yen, Chi, et al.
Publicado: (2021)

COVID-19, Ebola virus disease, and Nipah virus infection reclassification as novel acute immune dysrhythmia syndrome (n-AIDS): potential crucial role for immunomodulators
por: Kelleni, Mina T.
Publicado: (2021)

COVID19 therapeutics: Expanding the antiviral arsenal
por: Gallagher, Tom
Publicado: (2021)

Comparative Study of Cytokine Storm Treatment in Patients with COVID-19 Pneumonia Using Immunomodulators
por: Marc, Felicia, et al.
Publicado: (2022)

Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19
por: Efimov, Sergey V, et al.
Publicado: (2022)

COVID-19 and immunomodulation in IBD
por: Neurath, Markus F
Publicado: (2020)

Immunomodulation and immunotherapeutics of COVID-19
por: Garg, Sourbh Suren, et al.
Publicado: (2021)

COVID-19 and gut immunomodulation
por: Roy, Koushik, et al.
Publicado: (2021)

COVID-19 and immunomodulation treatment for women with reproductive failures
por: Kwak-Kim, Joanne, et al.
Publicado: (2020)

Key success factors of Mauritius in the fight against COVID-19
por: Musango, Laurent, et al.
Publicado: (2021)

Teams with lower injury rates have greater success in the Currie Cup rugby union competition
por: Starling, L T
Publicado: (2019)

COVID-19 and patient engagement in health research: What have we learned?
por: Denegri, Simon, et al.
Publicado: (2021)

OpenTrials: towards a collaborative open database of all available information on all clinical trials
por: Goldacre, Ben, et al.
Publicado: (2016)

Interpretation of the diagnosis and treatment protocol for COVID‐19 (Trial Version 9)
por: Rongmeng, Jiang
Publicado: (2022)

Rapid evaluation of the safety of COVID-19 vaccines: how well have we done?
por: Miller, Elizabeth
Publicado: (2022)

Influenza vaccination may have only minimum or no effect on COVID-19 in the aged population
por: Yao, Lan, et al.
Publicado: (2022)

Commentary: Success lies in attention to details when performing open repair of thoracoabdominal aneurysms
por: Lau, Christopher, et al.
Publicado: (2021)

Acute stroke: we have the treatments and we have the evidence – we need to use them
por: Quinn, Terence J, et al.
Publicado: (2007)

How Covid-19 opened up questions of sociomateriality in healthcare education
por: Cleland, Jennifer, et al.
Publicado: (2020)

Open science saves lives: lessons from the COVID-19 pandemic
por: Besançon, Lonni, et al.
Publicado: (2021)

Successful treatment of a Candida auris intra-articular infection
por: Roberts, Scott C., et al.
Publicado: (2019)

Immunopathogenesis of COVID-19 and early immunomodulators
por: Lee, Kyung-Yil, et al.
Publicado: (2020)

Cytokine Storm and Immunomodulation in COVID-19
por: Rangappa, Pradeep
Publicado: (2021)

Combining immunomodulators and antivirals for COVID-19
por: Chen, Luke Y C, et al.
Publicado: (2021)

Supporting successful recruitment in a randomized control trial comparing clinic and home-based exercise among adults with multiple sclerosis
por: Tracy, Tracy Flemming, et al.
Publicado: (2022)

Medical Staff Responses to COVID-19 ‘Data’: Have We Misplaced Our Skeptic's Eye?
por: Meisenberg, Barry R.
Publicado: (2021)

Proximal tubular dysfunction in patients with COVID-19: what have we learnt so far?
por: Braun, Fabian, et al.
Publicado: (2020)

COVID-19: What paramedics need to know!
por: Buick, Jason E., et al.
Publicado: (2020)

Predicting treatment success with biologics in psoriasis
por: van den Reek, J.M.P.A.
Publicado: (2019)

Macao's COVID-19 responses: From virus elimination success to vaccination rollout challenges
por: McCartney, Glenn, et al.
Publicado: (2021)

COVID-19: underpowered randomised trials, or no randomised trials?
por: Fretheim, Atle
Publicado: (2021)

Is Pakistan on track to have COVID-19 transmission and mortality rates similar to those of Italy, Iran or the USA?
por: Javed, Bilal, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6b5h2telcrp25ufd7rqri9f9cr